Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
33028 | 130 | 31.0 | 59% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
364 | 3 | TELOMERASE//TELOMERE//C ELEGANS | 34320 |
3283 | 2 | MECHANISMS OF AGEING AND DEVELOPMENT//EXPERIMENTAL GERONTOLOGY//CELLULAR AGING | 1891 |
33028 | 1 | ANTI CHOLESTEROL ANTIBODIES//NON BILAYER PHOSPHOLIPID ARRANGEMENTS//ANTIBODIES TO CHOLESTEROL | 130 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ANTI CHOLESTEROL ANTIBODIES | authKW | 528499 | 2% | 75% | 3 |
2 | NON BILAYER PHOSPHOLIPID ARRANGEMENTS | authKW | 528499 | 2% | 75% | 3 |
3 | ANTIBODIES TO CHOLESTEROL | authKW | 313184 | 2% | 67% | 2 |
4 | CONE SHAPED LIPIDS | authKW | 313184 | 2% | 67% | 2 |
5 | ACIDOTROPIC PH INDICATOR | authKW | 234889 | 1% | 100% | 1 |
6 | ANTI FATTY ACID ANTIBODY | authKW | 234889 | 1% | 100% | 1 |
7 | ANTI LIPID IGG ANTIBODIES | authKW | 234889 | 1% | 100% | 1 |
8 | ANTI LIPID IGM | authKW | 234889 | 1% | 100% | 1 |
9 | ANTIBODIES TO GALACTOSYLCERAMIDE | authKW | 234889 | 1% | 100% | 1 |
10 | ANTIBODIES TO LIPOSOMES | authKW | 234889 | 1% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Immunology | 359 | 26% | 0% | 34 |
2 | Biochemistry & Molecular Biology | 333 | 43% | 0% | 56 |
3 | Biophysics | 287 | 18% | 0% | 23 |
4 | Biochemical Research Methods | 68 | 8% | 0% | 11 |
5 | Chemistry, Multidisciplinary | 28 | 12% | 0% | 16 |
6 | Cell Biology | 26 | 9% | 0% | 12 |
7 | Crystallography | 10 | 3% | 0% | 4 |
8 | Pharmacology & Pharmacy | 4 | 6% | 0% | 8 |
9 | Chemistry, Organic | 3 | 4% | 0% | 5 |
10 | Dermatology | 2 | 2% | 0% | 2 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ENVIRONM IMMUNOANAL | 234889 | 1% | 100% | 1 |
2 | GENET DCBDC NIH | 234889 | 1% | 100% | 1 |
3 | GRP METAB ATHEROCLEROSIS | 234889 | 1% | 100% | 1 |
4 | IBCN NEUROIMMUNOL | 234889 | 1% | 100% | 1 |
5 | INMUNOL MOL 2 | 234889 | 1% | 100% | 1 |
6 | SPACE MANAGEMENT GRP | 234889 | 1% | 100% | 1 |
7 | US MIL HIV VACCINE PROGRAM | 234889 | 1% | 100% | 1 |
8 | VACCINE PROD DELIVERY | 211396 | 2% | 30% | 3 |
9 | GRP METAB GENET IMMUNOL | 55626 | 2% | 8% | 3 |
10 | VASC CARDIAC SURG | 21352 | 1% | 9% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BIOCHEMISTRY AND CELL BIOLOGY | 3270 | 2% | 1% | 2 |
2 | KHIMIKO-FARMATSEVTICHESKII ZHURNAL | 2291 | 4% | 0% | 5 |
3 | JOURNAL OF IMMUNOLOGICAL METHODS | 1551 | 6% | 0% | 8 |
4 | MOLECULAR MEMBRANE BIOLOGY | 1237 | 2% | 0% | 2 |
5 | CLINICAL IMMUNOTHERAPEUTICS | 934 | 1% | 0% | 1 |
6 | JOURNAL OF LIPID MEDIATORS | 858 | 1% | 0% | 1 |
7 | CHEMISTRY AND PHYSICS OF LIPIDS | 650 | 2% | 0% | 3 |
8 | MOLECULAR IMMUNOLOGY | 529 | 3% | 0% | 4 |
9 | BIOFIZIKA | 501 | 2% | 0% | 3 |
10 | JOURNAL OF LIPOSOME RESEARCH | 398 | 1% | 0% | 1 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | KARASAVVAS, N , BECK, Z , TONG, J , MATYAS, GR , RAO, M , MCCUTCHAN, FE , MICHAEL, NL , ALVING, CR , (2008) ANTIBODIES INDUCED BY LIPOSOMAL PROTEIN EXHIBIT DUAL BINDING TO PROTEIN AND LIPID EPITOPES.BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. VOL. 366. ISSUE 4. P. 982-987 | 11 | 61% | 6 |
2 | ALVING, CR , (2006) ANTIBODIES TO LIPIDS AND LIPOSOMES: IMMUNOLOGY AND SAFETY.JOURNAL OF LIPOSOME RESEARCH. VOL. 16. ISSUE 3. P. 157-166 | 18 | 37% | 12 |
3 | MATYAS, GR , WASSEF, NM , RAO, M , ALVING, CR , (2000) INDUCTION AND DETECTION OF ANTIBODIES TO SQUALENE.JOURNAL OF IMMUNOLOGICAL METHODS. VOL. 245. ISSUE 1-2. P. 1-14 | 12 | 63% | 26 |
4 | ALVING, CR , RAO, M , (2008) LIPID A AND LIPOSOMES CONTAINING LIPID A AS ANTIGENS AND ADJUVANTS.VACCINE. VOL. 26. ISSUE 24. P. 3036 -3045 | 21 | 26% | 23 |
5 | ALVING, CR , BECK, Z , KARASAVVA, N , MATYAS, GR , RAO, M , (2006) HIV-1, LIPID RAFTS, AND ANTIBODIES TO LIPOSOMES: IMPLICATIONS FOR ANTI-VIRAL-NEUTRALIZING ANTIBODIES (REVIEW).MOLECULAR MEMBRANE BIOLOGY. VOL. 23. ISSUE 6. P. 453-U1 | 22 | 21% | 11 |
6 | ALVING, CR , WASSEF, NM , POTTER, M , (1996) ANTIBODIES TO CHOLESTEROL: BIOLOGICAL IMPLICATIONS OF ANTIBODIES TO LIPIDS.IMMUNOLOGY OF SILICONES. VOL. 210. ISSUE . P. 181 -186 | 9 | 69% | 8 |
7 | KUZMINA, YV , KAPLUN, AP , SHVETS, VI , (1991) IMMUNOCHEMISTRY OF PHOSPHOLIPIDS.BIOLOGICHESKIE MEMBRANY. VOL. 8. ISSUE 10. P. 1013-1027 | 16 | 47% | 1 |
8 | GEVA, M , ADDADI, L , (2003) STEREOSPECIFIC AND STRUCTURE SPECIFIC RECOGNITION OF TWO- AND THREE-DIMENSIONALLY ORGANIZED SURFACES BY BIOLOGICAL MACROMOLECULES.MOLECULAR CRYSTALS AND LIQUID CRYSTALS. VOL. 390. ISSUE . P. 57 -66 | 8 | 53% | 1 |
9 | ADDADI, L , GEVA, M , (2003) MOLECULAR RECOGNITION AT THE INTERFACE BETWEEN CRYSTALS AND BIOLOGY: GENERATION, MANIFESTATION AND DETECTION OF CHIRALITY AT CRYSTAL SURFACES.CRYSTENGCOMM. VOL. . ISSUE . P. 140 -146 | 10 | 37% | 26 |
10 | ALVING, CR , WASSEF, NM , (1999) NATURALLY OCCURRING ANTIBODIES TO CHOLESTEROL: A NEW THEORY OF LDL CHOLESTEROL METABOLISM.IMMUNOLOGY TODAY. VOL. 20. ISSUE 8. P. 362-366 | 9 | 41% | 33 |
Classes with closest relation at Level 1 |